Company: BSTZ
Filing Date: 2025-03-07
Form Type: N-CSR
Source: 0001193125-25-049659
Chunk: 23

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-03-07
Form: N-CSR
Chunk 23
---
Trust Summary 23

Trust Summary as of December 31, 2024 BlackRock Health Sciences Trust (BME)

Investment Objective BlackRock Health Sciences Trust ’ s ( BME ) (the “ Trust ”) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and by employing a strategy of writing (selling) call and put options. No assurance can be given that the Trust’s investment objective will be achieved. Trust Information

| Symbol on New York Stock Exchange                                                     
 Initial Offering Date                                                                 
 Current Distribution Rate on Closing Market Price as of December 31, 2024 ($37.93)(a) |            BME 
 March 31, 2005 
          8.29% |
|:--------------------------------------------------------------------------------------|---------------:|
| Current Monthly Distribution per Common                                               
 Share(b)                                                                              |      $0.262100 |
| Current Annualized Distribution per Common Share(b)                                   |      $3.145200 |

| (a) | Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current 
 distribution rate mayconsist of income, net realized gains and/or a return of                                                                                      
 capital. Past performance is not an indication of future results.                                                                                                  |
| (b) | The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain.              |

Market Price and Net Asset Value Per Share Summary

|                      | 12/31/24 | 12/31/23 |  Change |   High |    Low |
| Closing Market Price |   $37.93 |   $40.46 | (6.25)% | $42.71 | $36.92 |
| Net Asset Value      |    41.20 |    42.18 |   -2.32 |  46.00 |  40.83 |

GROWTH OF $10,000 INVESTMENT (a) Represents the Trust’s closing market price on the NYSE and reflects the reinvestment of dividends and/or distributions at actual